Condition: Life-threatening Infection · Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
This study, aims to identify and calculate the prevalence of cases potentially associated with congenital errors of immunity (ECI) among patients, hospitalized with infectious disease and carry out their clinical-laboratory characterization. Diagnoses of ECI are becoming increasingly common, by virtue of the continuing discoveries of new disease-causing genes and an increasing understanding of the clinical signs and symptoms of these entities. The most important challenge still remains to achieve early diagnosis, which is essential for appropriate and individualized treatment that also takes into account the prognostic and genetic counseling aspect related to these disorders, which are associated with high rates of morbidity and mortality. Patients with nonimmunological diseases, secondary immunodeficiencies, nonpharmacological iatrogenic factors, and immunosuppressive drug therapies will be involved in the study.
This description comes directly from the study's public registry record.
Daniele Zama, MD · 0512144688 · daniele.zama2@unibo.it
Always discuss trial participation with your own doctor first.
| IRCCS Istituto delle Scienze Neurologiche | Bologna, Bologna, Italy | Recruiting |
| IRCCS Azienda Ospedaliero Universitaria di Bologna UO Pediatria | Bologna, Bologna, Italy | Recruiting |
| IRCCS Azienda-Ospedaliero Universitaria di Bologna UO Anestesiologia e Rianimazione generale e pediatrica | Bologna, Bologna, Italy | Recruiting |
| IRCCS Azienda-Ospedaliero Universitaria di Bologna UO Malattie Infettive | Bologna, Bologna, Italy | Recruiting |
| IRCCS Azienda-Ospedaliero Universitaria di Bologna UO Neonatologia e terapia intensiva neonatale | Bologna, Bologna, Italy | Recruiting |
| IRCCS Azienda-Ospedaliero Universitaria di Bologna UO Pediatria d'Urgenza, Pronto Soccorso e Osservazione Breve e Intensiva | Bologna, Bologna, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06775496